Axel Mark
3624
Renascience
4889
Ecomott
3987
Festaria Holdings
2736
Tecnisco
2962
(Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.34%2.25B | -2.54%2B | 2.89%8.61B | 6.88%2.44B | -8.22%1.96B | 7.61%2.15B | 5.59%2.05B | 5.40%8.37B | 4.90%2.28B | 13.78%2.14B |
Cost of revenue | 3.20%1.83B | -4.52%1.64B | 3.33%7.1B | 0.43%2B | -7.11%1.61B | 10.30%1.77B | 11.52%1.72B | 7.87%6.87B | 9.84%1.99B | 14.43%1.73B |
Gross profit | 9.58%420.08M | 7.74%358.05M | 0.89%1.51B | 50.77%440.36M | -12.91%356.22M | -3.31%383.36M | -17.20%332.34M | -4.61%1.5B | -19.69%292.08M | 11.11%409.02M |
Operating expense | 4.26%285.16M | 1.65%290.55M | -3.88%1.16B | -8.03%302.84M | -2.65%296.19M | -3.76%273.51M | -0.54%285.84M | 1.22%1.21B | -0.08%329.27M | 4.40%304.26M |
Selling and administrative expenses | ---- | ---- | -3.88%1.16B | ---- | ---- | ---- | ---- | 1.22%1.21B | ---- | ---- |
-Selling and marketing expense | ---- | ---- | -4.34%203.09M | ---- | ---- | ---- | ---- | 0.82%212.3M | ---- | ---- |
-General and administrative expense | ---- | ---- | -3.78%955.29M | ---- | ---- | ---- | ---- | 1.31%992.8M | ---- | ---- |
Operating profit | 22.82%134.92M | 45.15%67.5M | 20.43%353.92M | 469.79%137.53M | -42.69%60.03M | -2.17%109.85M | -59.21%46.51M | -22.83%293.87M | -208.89%-37.19M | 36.57%104.76M |
Net non-operating interest income (expenses) | 1.65%-3.88M | -9.88%-4.07M | -1.28%-15.45M | -5.14%-3.91M | -3.04%-3.89M | -2.95%-3.95M | 5.70%-3.7M | 7.13%-15.26M | 4.96%-3.72M | 10.52%-3.78M |
Non-operating interest income | 77.17%1.04M | -23.53%481K | 3.74%2.28M | 0.73%549K | -16.94%510K | 1.91%587K | 37.34%629K | 134.04%2.19M | 36.93%545K | 320.55%614K |
Non-operating interest expense | 8.56%4.92M | 5.03%4.55M | 1.59%17.73M | 4.58%4.46M | 0.25%4.4M | 2.81%4.54M | -1.21%4.33M | 0.48%17.45M | -1.09%4.26M | 0.55%4.39M |
Net investment income | 513.93%2.2M | 103.96%2.11M | -65.77%4.55M | 117.11%663K | -63.70%2.49M | -94.54%359K | -72.17%1.04M | 17.99%13.29M | -177.49%-3.88M | 640.31%6.86M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -162.30%-2.08M | 884.48%571K | 86.74%-2.57M | 91.47%-1.5M | -269.66%-329K | 52.29%-793K | 286.67%58K | -338.92%-19.34M | -3,048.84%-17.6M | -101.08%-89K |
Less:Other special charges | ---- | ---- | -86.74%2.57M | -91.47%1.5M | --0 | ---- | ---- | 334.57%19.34M | 3,048.84%17.6M | --0 |
Less:Write off | 75.65%-66K | -884.48%-571K | ---- | ---- | ---- | -266.22%-271K | -286.67%-58K | ---- | ---- | ---- |
Other non-operating income (expenses) | 209.22%11.61M | -58.76%857K | -85.66%1.57M | -49.82%1.38M | -452.09%-5.65M | 50.04%3.75M | -48.68%2.08M | 20.78%10.91M | 58.51%2.76M | -61.89%1.61M |
Income before tax | 69.76%185.42M | 45.69%66.98M | 20.65%342.01M | 325.00%134.16M | -51.85%52.65M | -5.74%109.23M | -61.00%45.97M | -28.04%283.47M | -263.70%-59.63M | 28.95%109.36M |
Income tax | 42.70%42.26M | 256.81%17.32M | 33.84%86.49M | 383.64%36.79M | -33.45%15.24M | -7.71%29.61M | -78.53%4.85M | -42.64%64.62M | -188.60%-12.97M | 11.50%22.89M |
Net income | 79.83%143.17M | 20.77%49.66M | 16.76%255.53M | 308.70%97.38M | -56.73%37.42M | -4.99%79.61M | -56.83%41.12M | -22.19%218.86M | -314.16%-46.66M | 34.52%86.47M |
Net income continuous operations | 79.83%143.17M | 20.77%49.66M | 16.75%255.53M | 308.70%97.38M | -56.73%37.42M | -4.98%79.62M | -56.83%41.12M | -22.19%218.86M | -314.16%-46.66M | 34.52%86.47M |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | |||||
Net income attributable to the company | 79.83%143.17M | 20.77%49.66M | 16.76%255.53M | 308.70%97.38M | -56.73%37.42M | -4.99%79.61M | -56.83%41.12M | -22.19%218.86M | -314.16%-46.66M | 34.52%86.47M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 79.83%143.17M | 20.77%49.66M | 16.76%255.53M | 308.70%97.38M | -56.73%37.42M | -4.99%79.61M | -56.83%41.12M | -22.19%218.86M | -314.16%-46.66M | 34.52%86.47M |
Gross dividend payment | ||||||||||
Basic earnings per share | 79.80%117.59 | 20.79%40.79 | 16.76%209.88 | 308.72%79.98 | -56.72%30.73 | -4.97%65.4 | -56.84%33.77 | -22.18%179.75 | -313.96%-38.32 | 34.54%71.01 |
Diluted earnings per share | 79.82%117.59 | 20.79%40.79 | 16.76%209.88 | 308.70%79.98 | -56.72%30.73 | -4.98%65.393 | -56.84%33.77 | -22.18%179.75 | -314.17%-38.3238 | 34.54%71.01 |
Dividend per share | 0 | 0 | 0.00%50 | 0.00%50 | 0 | 0 | 0 | 0.00%50 | 0.00%50 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |